Example: Heart Attack

Search clinical trials for: Amikacin

Total 92 results

NCT04470973

Not yet recruiting

Pharmacokinetics of Amikacin and Cefuroxime in Critically Ill Patients.

Conditions: Sepsis; Septic Shock; Infection, Bacterial; Critically Ill
NCT04322019

Recruiting

Prescription Strategies of Amikacin in Intensive Care Patients on Renal Replacement Therapy: an Observational Prospective Multicenter Study

Conditions: Amikacin Treatment
NCT04310930

Recruiting

Finding the Optimal Regimen for Mycobacterium Abscessus Treatment

Conditions: Pulmonary Disease Due to Mycobacteria (Diagnosis)
NCT04285320

Not yet recruiting

Antibiotic Bladder Instillations vs. Oral Suppression for the Treatment of Recurrent Urinary Tract Infections

Conditions: Recurrent Urinary Tract Infection
NCT04249531

Recruiting

Pharmacokinetic Evaluation and Local Tolerability of Dry Powder Amikacin Via the Cyclops™

Conditions: Tuberculosis
NCT04209192

Recruiting

Antimicrobial Prophylaxis in Patients Who Underwent a Transurethral Resection of Bladder (TURB)

Conditions: Urinary Tract Infections; Bladder Cancer; Urologic Surgical Procedures
NCT04197739

Not yet recruiting

Fixed-dose Amikacin for Elderly UTI

Conditions: Urinary Tract Infections; Elderly Infection
NCT04178148

Recruiting

Personalized Dose Optimization of Amikacin Guided by Pharmacokinetic Modeling Software in Patients With Septic Shock

Conditions: Shock, Septic
NCT04163601

Recruiting

Liposomal Amikacin Inhalation in M.Abscessus Patients

Conditions: M.Abscessus Pulmonary Disease
NCT04132115

Recruiting

Optimized Antibiotic Therapy in Patients With Subarachnoid Haemorrhage (ES) and Cerebral Haemorrhage (EC)

Conditions: Therapeutic Drug Monitoring; Subarachnoid Hemorrhage; Intracerebral Hemorrhage
NCT04035369

Recruiting

Endophthalmitis Post Intravitreal Injections

Conditions: Endophthalmitis
NCT03990467

Not yet recruiting

Observed Pharmacokinetic of Piperacillin/Tazobactam Compared to Amikacin in ICU

Conditions: Septic Shock; Sepsis; Sepsis Syndrome
NCT03921645

Recruiting

Use of Aaerosol Combined With Intravenous Antibiotics for the Treatment of Multidrug Resistant GNB Pneumonia

Conditions: Ventilator Associated Pneumonia; Multi-antibiotic Resistance
NCT03905642

Completed

Study of Dose Escalation of Liposomal Amikacin for Inhalation (ARIKAYCE™) - Extension Phase

Conditions: Cystic Fibrosis
NCT03867136

Recruiting

Refining MDR-TB Treatment (T) Regimens (R) for Ultra(U) Short(S) Therapy(T)

Conditions: Multidrug Resistant Tuberculosis
NCT03830671

Recruiting

The Effect of 18-month Regimen Containing 6 Anti-tuberculosis Drugs for Patients With MDR-TB

Conditions: Multi-drug Resistant Tuberculosis
NCT03825874

Recruiting

Research of the Consequences on the Digestive Tract Following the Proposed Treatments for a Urinary Infection in Children

Conditions: Urinary Tract Infections; Urinary Tract Infections in Children
NCT03683511

Completed

Nomograms for Optimization of Amikacin First Dose in Critically Ill Patients Using a Population Pharmacokinetics Model

Conditions: Pharmacokinetics
NCT03625739

Recruiting

Population Pharmacokinetics of Anti-tuberculosis Drugs in Children With Tuberculosis

Conditions: Tuberculosis
NCT03622450

Completed

The Effect of Colistin Inhalation on Ventilator Associated Pneumonia

Conditions: Ventilator Associated Pneumonia
NCT03604848

Not yet recruiting

NGS-Guided(G) Regimens(R) of Anti-tuberculosis(A) Drugs for the Control(C) and Eradication(E) of MDR-TB

Conditions: Multidrug Resistant Tuberculosis
NCT03449459

Not yet recruiting

Prevention of Acute Exacerbation in Subjects With COPD by Bacterial Decolonization in Lower Respiratory Tract

Conditions: Chronic Obstructive Pulmonary Disease (COPD)
NCT03409679

Terminated

Pivotal Study in VAP Suspected or Confirmed to be Due to Pseudomonas Aeruginosa

Conditions: Pneumonia
NCT03237182

Recruiting

The Individualized M(X) Drug-resistant TB Treatment Strategy Study

Conditions: Tuberculosis, Multidrug-Resistant
NCT03169114

Terminated

Raja Isteri Pengiran Anak Saleha Appendicitis Treatment Without Operation

Conditions: Appendicitis; Surgery
NCT03149640

Recruiting

Study Comparing Inhaled Amikacin Versus Placebo to Prevent Ventilator Associated Pneumonia

Conditions: Pneumonia, Ventilator-Associated
NCT03147807

Unknown status

BetaLACTA® Test for Early De-escalation of Empirical Carbapenems in Pulmonary, Urinary and Bloodstream Infections in ICU

Conditions: Pneumonia; Urinary Tract Infections; Bloodstream Infection
NCT03038178

Completed

Liposomal Amikacin for Inhalation (LAI) in the Treatment of Mycobacterium Abscessus Lung Disease

Conditions: Mycobacterium Infections, Nontuberculous; Mycobacteria, Atypical
NCT02975570

Withdrawn

Efficacy and Tolerability of Delamanid, Linezolid, Pyrazinamide and Levofloxacin

Conditions: Tuberculosis Multi Drug Resistant Active
NCT02897869

Completed

DDI Study to Investigate Interaction Between Amikacin and POL7080

Conditions: Healthy
NCT02898961

Completed

Impact of 30 mg/kg Amikacin and 8 mg/kg Gentamicin on Serum Concentrations in Critically Ill Patients With Severe Sepsis

Conditions: Sepsis
NCT02872272

Unknown status

Amikacin Pharmacokinetic Profile in Plasma and Tissue After an Administration Using Impregnated Dressings in Burned Patient Population

Conditions: Burn Patients
NCT02850029

Completed

An International Survey on Aminoglycoside Practices in Critically Ill Patients: AMINO III Survey

Conditions: Underdosing of Aminoglycosides; Critical Illness
NCT02728518

Completed

Nebulized Amikacin Versus Intravenous Amikacin in the Treatment of Nosocomial Pneumonia

Conditions: Pneumonia
NCT02716883

Unknown status

Early Amniotic Membrane Transplantation in Bacterial Keratitis

Conditions: Keratitis of Both Eyes
NCT02709265

Completed

Open-Label Phase 1 Study of Aerosolized Amikacin and Fosfomycin in Healthy Volunteers

Conditions: Healthy
NCT02652169

Unknown status

PRF With Topical Antibiotics or Antiseptics in Chronical Wounds Version 1.4

Conditions: Chronic Skin Ulcer
NCT02628600

Completed

Open-label Safety Extension Study Assessing Safety and Tolerability of LAI in Patients Who Participated in Study INS-212

Conditions: NTM Lung Infection Due to MAC
NCT02574130

Completed

Effect of Additional Nebulized Amikacin in Ventilator-Associated Pneumonia Caused by Gram Negative Bacteria

Conditions: Pneumonia, Ventilator-Associated
NCT02538588

Unknown status

Comparison of Amikacin Lung Delivery With Two Nebulizers

Conditions: Healthy; Cystic Fibrosis
NCT02535130

Unknown status

Evaluation of Nebulization and Positive Expiratory Pressure Combination

Conditions: Cystic Fibrosis; Healthy Subjects
NCT02509091

Unknown status

Therapy of Bronchoalveolar Lavage and Local Amikacin Injection in Patients With Acute Exacerbation of Bronchiectasis

Conditions: Bronchiectasis
NCT02489955

Unknown status

Antibiotic Nephrotoxicity in Adult Patients With Cystic Fibrosis

Conditions: Cystic Fibrosis
NCT02456974

Recruiting

Antibiotic Dosing in Pediatric Intensive Care

Conditions: Pharmacokinetics; Amoxicillin-clavulanate; Piperacillin-tazobactam; Vancomycin; Teicoplanin; Meropenem; Ciprofloxacin; Amikacin
NCT02365623

Completed

An Exploratory Study of TMC207 in Japanese Participants With Pulmonary Multi-Drug Resistant Tuberculosis (MDR-TB)

Conditions: Tuberculosis, Multidrug-Resistant
NCT02365272

Completed

Pharmacokinetic/Pharmacodynamic Evaluation Amikacin in Critically Ill Patients Admitted at the Emergency Department

Conditions: Sepsis
NCT02344004

Completed

Study to Evaluate Efficacy of LAI When Added to Multi-drug Regimen Compared to Multi-drug Regimen Alone

Conditions: Mycobacterium Infections, Nontuberculous
NCT02277808

Unknown status

Which Apparatus for Inhaled Pentamidine?

Conditions: Healthy
NCT02218359

Withdrawn

Aerosolized Amikacin and Fosfomycin in Mechanically Ventilated Patients With Gram-negative and / or Gram-positive Bacterial Colonization

Conditions: Pneumonia, Bacterial
NCT02201082

Completed

Evaluation of the Timing of the Nebulization Related to the Physiotherapy Session

Conditions: Cystic Fibrosis